Hoshi University · Department of Pharmacy / Faculty of Pharmaceutical Sciences

Research keywordscancer epigenetics・DNA methylation・uterine cancer・ovarian cancer・breast cancer biomarkers・immune checkpoint therapy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Clinical features and impact of p53 status on sporadic mismatch repair deficiency and Lynch syndrome in uterine cancer.2024 · Cancer science
• HSD17B4 methylation enhances glucose dependence of BT-474 breast cancer cells and increases lapatinib sensitivity2023 · Breast Cancer Research and Treatment
• A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumors.2022 · Cancer chemotherapy and pharmacology
• DNA methylation marker to estimate ovarian cancer cell fraction.2022 · Medical oncology (Northwood, London, England)

• FERMT2メチル化を利用したがん特異的なインテグリン経路阻害薬の開発2023 · 科学研究費助成事業 若手研究
• 術前化学療法後卵巣がんを用いた治療抵抗性をきたす遺伝子メチル化の同定と機序の解明2020 · 科学研究費助成事業 若手研究
• 肺神経内分泌癌におけるHedgehog 経路の治療標的の可能性の探索2014 · 科学研究費助成事業 若手研究(B)

• Official profile